Low TREM1 expression in whole blood predicts anti-TNF response in inflammatory bowel diseaseResearch in context
Background: With the changed therapeutic armamentarium for Crohn's disease (CD) and ulcerative colitis (UC), biomarkers predicting treatment response are urgently needed. We studied whole blood and mucosal expression of genes previously reported to predict outcome to anti-TNF therapy, and inves...
Main Authors: | Bram Verstockt, Sare Verstockt, Jonas Dehairs, Vera Ballet, Helene Blevi, Willem-Jan Wollants, Christine Breynaert, Gert Van Assche, Séverine Vermeire, Marc Ferrante |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-02-01
|
Series: | EBioMedicine |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352396419300325 |
Similar Items
-
Monocyte TREM-1 Levels Associate With Anti-TNF Responsiveness in IBD Through Autophagy and Fcγ-Receptor Signaling Pathways
by: Marileen M. Prins, et al.
Published: (2021-03-01) -
Inflammatory Bowel Disease (IBD)—A Textbook Case for Multi-Centric Banking of Human Biological Materials
by: Isabelle Cleynen, et al.
Published: (2019-10-01) -
New biologics and small molecules in inflammatory bowel disease: an update
by: João Sabino, et al.
Published: (2019-05-01) -
Biological Therapy in Inflammatory Bowel Disease Patients Partly Restores Intestinal Innate Lymphoid Cell Subtype Equilibrium
by: Brecht Creyns, et al.
Published: (2020-08-01) -
Effects of Epithelial IL-13Rα2 Expression in Inflammatory Bowel Disease
by: Bram Verstockt, et al.
Published: (2018-12-01)